Analysis of miRNA expression profile induced by short term starvation in breast cancer cells treated with doxorubicin
Metrics: PDF 975 views | HTML 1383 views | ?
Sergio Rizzo1,*, Antonina Cangemi1,*, Antonio Galvano1,*, Daniele Fanale1, Silvio Buscemi2, Marcello Ciaccio3, Antonio Russo1, Sergio Castorina4,5,# and Viviana Bazan1,#
1Department of Surgical, Oncological and Oral Sciences, Section of Medical Oncology, University of Palermo, Palermo, Italy
2Department of Internal and Specialistic Medicine (DIBIMIS), Laboratory of Clinical Nutrition, University of Palermo, Palermo, Italy
3Section of Clinical Biochemistry and Clinical Molecular Medicine, Department of Biopathology and Medical Biotechnology, University of Palermo, U.O.C. Laboratory Medicine, Policlinico University Hospital, Palermo, Italy
4Fondazione Mediterranea "G.B. Morgagni", Catania, Italy
5Department of Biomedical and Biotechnological Sciences, University of Catania, Catania, Italy
*These authors contributed equally to this work
#These authors contributed equally to this work and co-last authors
Antonio Russo, email: firstname.lastname@example.org
Keywords: chemotherapy response, doxorubicin, microRNAs, short term starvation, triple negative breast cancer cells
Received: April 13, 2017 Accepted: May 09, 2017 Published: May 19, 2017
Recent studies showed that dietary approaches restricting food intake can be helpful to hinder tumor progression. To date, the molecular mechanisms are unclear and a key role seems to be exerted by nutrient-related signaling pathways. Since several evidences showed that non-coding small RNAs, including microRNAs, are correlated to cancer progression and antiblastic treatment response, our work aims to study their involvement in a triple negative breast cancer (TNBC) cell line treated with doxorubicin under Short Term Starvation (STS) condition.
Human TNBC cell line MDA-MB-231 and healthy breast cell line MCF10A were treated with 1 μM doxorubicin for 24 h under STS condition for 48 h and miRNA expression profiles were analyzed using Taqman® Low Density Array A human microRNA microfluidic cards. In addition, the expression of specific mRNAs and miRNAs differentially expressed under STS was analyzed using Real-time PCR analyses.
MiRNA expression profile analysis in MDA-MB-231 and MCF10A cells treated with doxorubicin under STS for 48 h could explain the molecular mechanisms underlying anticancer effects associated to STS. Among deregulated miRNAs, a subset, including miR-15b, miR-23a, miR-26a, miR-29a, miR-106b, miR-128, miR-149, miR-181a, miR-192, miR-193b, miR-195, miR-324-3p and miR-494, has been shown to be involved in pathways related to drug sensitivity/resistance.
The obtained data from our study suggest a potential involvement of some miRNAs in molecular pathways mediating the anticancer effects of STS in doxorubicin-treated breast cancer cells. Preliminary results seem to be encouraging and, in future, could allow the discovery of new potential targets useful for the development of new therapeutic approaches.
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.